Opportunity

DIBBS #SPE2DP-26-T-3612

DLA Solicitation for Moxifloxacin Hydrochloride Tablets (400 mg, 30-count bottles)

Posted

June 02, 2026

Respond By

June 08, 2026

Identifier

SPE2DP-26-T-3612

NAICS

424210

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain is soliciting offers for the supply of Moxifloxacin Hydrochloride 400 mg tablets (30 tablets per bottle) for delivery to multiple military and federal locations. - Government Buyer: - Defense Logistics Agency (DLA), Troop Support Medical Supply Chain Pharm FSA - Contracting office at 700 Robbins Avenue, Philadelphia, PA - OEMs (Original Equipment Manufacturers): - TEVA PHARMACEUTICALS USA, INC. (part number NDC00093-7387-56) - RISING PHARMA HOLDINGS, INC. (part number NDC57237-0156-30) - Products Requested: - Moxifloxacin Hydrochloride Tablets, 400 mg, 30 tablets per bottle - NSN: 6505-01-503-4772 - Quantities: 31, 3, and 12 bottles (total 46 bottles) - Must comply with Medical Marking Standard No. 1A and MIL-STD-129 for packaging and labeling - Storage at controlled room temperature required - Delivery Locations: - Navy Expeditionary Central Facility, Williamsburg, VA - 2nd CS BN CO A Distribution, Rose Barracks, Vilseck, Germany - USS Paul Hamilton DDG 60, FPO AP - Notable Requirements: - Only approved sources (TEVA and RISING PHARMA) are acceptable - Compliance with domestic sourcing laws and prohibitions on covered defense telecommunications equipment - Fast award process; delivery required within 20 days of order

Description

MOXIFLOXACIN HYDROC (QTY: 3, NSN: 6505-01-503-4772, Purchase Request: 7016898067) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

MOXIFLOXACIN HYDROC (QTY: 31, NSN: 6505-01-503-4772, Purchase Request: 7005876959) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

MOXIFLOXACIN HYDROC (QTY: 12, NSN: 6505-01-503-4772, Purchase Request: 7016978811) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.

View original listing